For the past 17 years, attendance at the International Society of Pharmacoeconomics and Outcomes Research (ISPOR) Annual International Meeting has grown from under 500 in attendance at the first conference held in 1996 to an expected turnout of more than 3,000 during the May 18-22, 2013 meeting in New Orleans.
ISPOR, the leading international organization focused on promoting and improving the use of health economics and outcomes research in health policy, will devote its meeting to patient-centered outcomes research, evidence and drug development. Speakers from all over the world will be on-hand to discuss effectiveness research and drug development. There will be more than 1,600 presentations, 15 issues panels, and 31 workshops, all addressing patient-centered outcomes and the importance of focusing on patients.
This year, Optum will present an educational symposium titled “Analyze This! Getting the Right Data for Research and Evidence Generation,” where Aylin Altan Riedel, PhD, Principal Consultant, Optum Life Sciences, will moderate a panel which also includes Lewis G. Sandy, MD, FACP, Senior Vice President, Clinical Advancement, UnitedHealth Group and Linus Jonsson, MD, MSc, PhD, Executive Vice President and Senior Scientist, Optum Life Sciences. This symposium will offer insight into the challenge of assembling the right data for the research question or evidence generation agenda in the current information technology, policy and regulatory environment. For a full schedule of Optum’s contributions to the ISPOR meeting visit Optum.com.
As President-elect of ISPOR, I’m thrilled that we will have a wide range of perspectives represented at the meeting, ranging from patient advocates to pharmaceutical companies to FDA and PCORI, all with the patient at the center of the discussion. Even if you can’t be there in person, I encourage you to participate via social media. To follow the ISPOR conference, join the Twitter discussion at @OptumNews to read more about what our organization is doing at the meeting and/or follow additional discussion at @ISPORorg and #ISPORNewOrleans.